DENTSPLY SIRONA (NASDAQ:XRAY) PT Lowered to $33.00 at Robert W. Baird

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price reduced by Robert W. Baird from $35.00 to $33.00 in a research note issued to investors on Friday morning, Benzinga reports. They currently have a neutral rating on the medical instruments supplier’s stock.

Other equities analysts have also recently issued research reports about the company. StockNews.com upgraded DENTSPLY SIRONA from a hold rating to a buy rating in a report on Friday, January 19th. Needham & Company LLC reissued a buy rating and issued a $42.00 target price on shares of DENTSPLY SIRONA in a research report on Thursday, February 29th. Leerink Partnrs reaffirmed an outperform rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. SVB Leerink assumed coverage on shares of DENTSPLY SIRONA in a report on Monday, February 26th. They issued an outperform rating and a $42.00 price objective on the stock. Finally, Piper Sandler boosted their price objective on shares of DENTSPLY SIRONA from $31.00 to $35.00 and gave the stock a neutral rating in a research report on Friday, January 12th. Five investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of Moderate Buy and a consensus target price of $35.89.

DENTSPLY SIRONA Trading Down 0.3 %

NASDAQ XRAY opened at $28.29 on Friday. DENTSPLY SIRONA has a one year low of $26.27 and a one year high of $41.65. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.43 and a quick ratio of 0.95. The firm has a market cap of $5.87 billion, a P/E ratio of -64.29, a P/E/G ratio of 1.15 and a beta of 1.00. The stock’s 50-day moving average is $32.13 and its 200-day moving average is $32.71.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, hitting the consensus estimate of $0.42. The firm had revenue of $953.00 million for the quarter, compared to the consensus estimate of $969.45 million. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The business’s quarterly revenue was down 2.6% on a year-over-year basis. During the same period last year, the company posted $0.39 EPS. Sell-side analysts anticipate that DENTSPLY SIRONA will post 2.04 earnings per share for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were paid a $0.16 dividend. The ex-dividend date of this dividend was Wednesday, March 27th. This represents a $0.64 dividend on an annualized basis and a yield of 2.26%. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -145.45%.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of XRAY. Exchange Traded Concepts LLC grew its holdings in DENTSPLY SIRONA by 41.2% during the third quarter. Exchange Traded Concepts LLC now owns 1,504 shares of the medical instruments supplier’s stock worth $51,000 after purchasing an additional 439 shares during the period. Asset Management One Co. Ltd. lifted its position in shares of DENTSPLY SIRONA by 5.0% in the third quarter. Asset Management One Co. Ltd. now owns 89,835 shares of the medical instruments supplier’s stock valued at $3,069,000 after buying an additional 4,294 shares during the last quarter. Xponance Inc. boosted its stake in shares of DENTSPLY SIRONA by 12.4% during the 3rd quarter. Xponance Inc. now owns 37,292 shares of the medical instruments supplier’s stock worth $1,274,000 after acquiring an additional 4,114 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of DENTSPLY SIRONA by 132.4% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 83,817 shares of the medical instruments supplier’s stock worth $2,863,000 after acquiring an additional 47,748 shares during the last quarter. Finally, Strs Ohio raised its stake in DENTSPLY SIRONA by 14.6% in the 3rd quarter. Strs Ohio now owns 47,167 shares of the medical instruments supplier’s stock valued at $1,611,000 after acquiring an additional 6,021 shares during the period. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.